CNS-7056
CNS-7056 structure
|
Common Name | CNS-7056 | ||
|---|---|---|---|---|
| CAS Number | 308242-62-8 | Molecular Weight | 439.30500 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H19BrN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CNS-7056Remimazolam (CNS-7056) is a short-acting GABA(A) receptor agonist[1]. |
| Name | Remimazolam |
|---|---|
| Synonym | More Synonyms |
| Description | Remimazolam (CNS-7056) is a short-acting GABA(A) receptor agonist[1]. |
|---|---|
| Related Catalog | |
| Target |
GABA(A) receptor[1] |
| References |
| Molecular Formula | C21H19BrN4O2 |
|---|---|
| Molecular Weight | 439.30500 |
| Exact Mass | 438.06900 |
| PSA | 69.37000 |
| LogP | 3.61910 |
| Storage condition | 2-8℃ |
|
~88%
CNS-7056 CAS#:308242-62-8 |
| Literature: CeNes Limited Patent: EP1183243 B1, 2006 ; Location in patent: Page/Page column 36; 37 ; |
|
~73%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; Location in patent: Page/Page column 11 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; Location in patent: Page/Page column 11-12 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
|
~%
CNS-7056 CAS#:308242-62-8 |
| Literature: PAION UK Limited Patent: EP2305647 A1, 2011 ; |
![methyl 3-((3S)-7-bromo-2-((2-hydroxypropyl)imino)-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate structure](https://image.chemsrc.com/caspic/406/308243-54-1.png)
![3-[(S)-7-bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-propionic acid methyl ester structure](https://image.chemsrc.com/caspic/225/1275616-59-5.png)
![3-[(S)-7-bromo-2-(2-oxo-propylamino)-5-pyridin-2-yl-3H-1,4-benzodiazepin-3-yl]-propionic acid methyl ester structure](https://image.chemsrc.com/caspic/332/1275616-61-9.png)
![(3S)-(7-Bromo-2-oxo-5-pyridin-2-yl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-propionic acid Methyl ester structure](https://image.chemsrc.com/caspic/421/308242-23-1.png)
![(S)-methyl 3-(7-bromo-2-((dimorpholinophosphoryl)oxy)-5-(pyridin-2-yl)-3H-benzo[e][1,4]diazepin-3-yl)propanoate structure](https://image.chemsrc.com/caspic/370/1275616-60-8.png)
| methyl (S)-3-(8-bromo-1-methyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo[1,2-a][1,4]diazepin-4-yl)propanoate |
| methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propanoate |
| IMI030 |
| CNS 7056 |
| CN-7056 |